Healthcare, Pharma & Life Sciences

AAOS Presses CMS to Reverse Orthopaedic Payment Cuts in 2027 Fee Schedule

Image
AAOS Presses CMS to Reverse Orthopaedic Payment Cuts in 2027 Fee Schedule

Washington – September 18, 2026 -- The American Association of Orthopaedic Surgeons (AAOS) submitted a formal comment letter to the Centers for Medicare & Medicaid Services (CMS) opposing proposed payment cuts in the calendar year 2027 Medicare Physician Fee Schedule, warning the changes could accelerate consolidation among independent orthopaedic practices.

AAOS demands CMS preserve current work RVUs for major joint procedures

The letter urges CMS to maintain calendar year 2026 work relative value units (RVUs) for total shoulder, total hip, and total knee arthroplasty services, along with shoulder hemiarthroplasty. AAOS argues that reducing these values would compound years of what it calls inadequate payment updates and rising practice costs.

NHI Builds $608M Pipeline Ahead of BofA Real Estate Conference

Image
NHI Builds $608M Pipeline Ahead of BofA Real Estate Conference

Murfreesboro – September 18, 2026 -- National Health Investors (NYSE: NHI) has amassed approximately $608.7 million in combined investment opportunities as management prepares to meet investors at the BofA Securities 2026 Global Real Estate Conference on September 15.

NHI holds $272.0 million under signed letters of intent for new acquisitions

The senior housing REIT disclosed that it currently has roughly $272.0 million of investment opportunities under signed Letters of Intent, alongside an additional $51.7 million tied to real estate purchase options.

Company plans to deploy 1031 exchange proceeds from NHC portfolio sale

NHI expects to use proceeds from a Section 1031 exchange transaction initiated by its NHC portfolio sale to fund a significant portion of these committed opportunities. Completing the exchanges would defer recognition of a substantial share of the taxable gain generated by the NHC sale.

Lavender Names Two Clinical Leaders as Telepsychiatry Network Grows

Image
Lavender Names Two Clinical Leaders as Telepsychiatry Network Grows

New York – September 18, 2026 -- Lavender, the largest nurse-owned telepsychiatry practice in the United States, has appointed Kara Birch, DNP, PMHNP-BC, FNP-BC, as Director of Clinical Excellence and Anna Lau, MSN, PMHNP-BC, WHNP-BC, as Director of Nursing Operations, formalizing leadership over a network of more than 140 nurse practitioners operating across more than 40 states.

Rx relief Marks National Staffing Employee Week for Pharmacy Talent

Image
Rx relief Marks National Staffing Employee Week for Pharmacy Talent

Fresno, Calif. – September 18, 2026 -- Rx relief, a Joint Commission Certified pharmacy staffing division of PrideStaff, is marking National Staffing Employee Week, running Sept. 14-20, to recognize pharmacy professionals placed across U.S. healthcare organizations.

American Staffing Association designates the week to highlight temporary and contract workforce contributions

The observance, held annually by the American Staffing Association, spotlights the role temporary and contract employees play in supporting U.S. businesses and the broader economy, while underscoring career pathways staffing firms offer workers nationwide.

Endpoint Clinical Acquires Bluefin to Merge RTSM With Supply Forecasting

Image
Endpoint Clinical Acquires Bluefin to Merge RTSM With Supply Forecasting

Raleigh – September 18, 2026 -- Endpoint Clinical L.P., a portfolio company of Arsenal Capital Partners, has acquired Boston-based Bluefin, a clinical supply forecasting and planning technology provider, expanding Endpoint's footprint from randomization and trial supply management (RTSM) into upstream supply chain planning.

Bluefin will keep operating independently across all RTSM platforms

Under the deal, Bluefin will continue to run as a standalone, RTSM-agnostic business, connecting with RTSM systems industry-wide rather than being folded exclusively into Endpoint's technology stack. Endpoint will provide global project management, implementation, quality and customer support resources to help sponsors deploy Bluefin's platform at scale.

Senior Helpers Greenville Becomes First US Home Care Firm CHAP-Certified

Image
Senior Helpers Greenville Becomes First US Home Care Firm CHAP-Certified

Greenville, S.C. – September 18, 2026 -- Senior Helpers Greenville has become the first private duty in-home care provider in the United States to earn Age-Friendly Care at Home certification from the Community Health Accreditation Partners (CHAP), the locally owned franchise confirmed September 18, 2026.

CHAP certification validates a 4Ms clinical framework across daily operations

The certification requires providers to embed the 4Ms Framework -- What Matters, Medication, Mentation, and Mobility -- into every client interaction, a research-backed model designed to reduce hospitalization risk and improve outcomes for aging-in-place seniors. Teresa Harbour, COO of CHAP, credited the location's prior deployment of clinical tools, including its LIFE Profile hospitalization-risk assessment and Senior Gems dementia care program, as groundwork that made the certification a natural extension of existing practice.

Prime IV Adds BHRT, Niagen Therapy Across Wellness Franchise Network

Image
Prime IV Adds BHRT, Niagen Therapy Across Wellness Franchise Network

Colorado Springs – September 18, 2026 -- Prime IV Hydration & Wellness has added Bioidentical Hormone Replacement Therapy (BHRT) and Niagen, a patented NAD+ precursor, to its service menu at select locations across its 215-plus site franchise network.

Prime IV expands physician-guided hormone therapy to address andropause and menopause symptoms

The BHRT program uses compounded bioidentical hormones delivered via a 100% USDA Certified Organic, solvent-free topical base designed for rapid absorption and minimized transfer risk. The offering includes initial consultation, personalized treatment planning, and ongoing provider access, targeting symptoms such as fatigue, mood changes, sleep disruption, brain fog, low libido, weight changes and decreased vitality. Prime IV has structured separate membership tracks for men and women to address andropause and perimenopause/menopause respectively.

Doceree Adds CTV, Social, Programmatic to Real-Time HCP Ad Platform

Image
Doceree Adds CTV, Social, Programmatic to Real-Time HCP Ad Platform

Short Hills, N.J. – September 18, 2026 -- Doceree has launched Intent Powered HCP Suite, extending its real-time clinical signal technology into Connected TV, LinkedIn and programmatic advertising, three channels the company says still rely on claims data that lags weeks behind actual prescribing decisions.

Doceree unifies three high-spend channels under one clinical signal layer

The suite, unveiled at the opening of Fierce Pharma Week 2026, adds CTV, Social and Programmatic to Doceree's existing Care Sequence and digital out-of-home (DOOH) offerings. All channels run through Daily Command, Doceree's pharma commercialization operating system, allowing a single physician-level clinical signal to trigger a CTV impression, a LinkedIn placement and a programmatic bid in sequence.

Spa Medicca Adds Dr. Sherock & Associates to Ohio Women's Health Network

Image
Spa Medicca Adds Dr. Sherock & Associates to Ohio Women's Health Network

Canton, Ohio – September 18, 2026 -- Spa Medicca has finalized a partnership with Dr. Sherock & Associates, a women's health practice serving Massillon and Orrville, Ohio, marking the medical aesthetics and wellness platform's latest acquisition in the state.

Seven Hills Capital financed the transaction as Spa Medicca's private equity partner

Seven Hills Capital, an operator-centric healthcare private equity firm, served as Spa Medicca's financial partner in completing the deal and will continue backing the organization's regional expansion strategy.

Inductive Bio Launches Indy, AI Chemistry Agent Beating GPT-5.6, Claude Opus 5

Image
Inductive Bio Launches Indy, AI Chemistry Agent Beating GPT-5.6, Claude Opus 5

NEW YORK – September 18, 2026 -- Inductive Bio has launched Indy, an AI medicinal chemistry agent that scored 89% accuracy on 84 real-program dose-response curves, versus 48% for Claude Opus 5 and 39% for GPT-5.6 Sol run at maximum effort settings.

Indy has doubled chemist productivity inside live partner drug discovery programs

Inductive Bio built Indy internally with its medicinal chemists, computational chemists and DMPK scientists, then deployed it across active partner programs before today's public launch. The company reports the tool doubled team productivity by taking over data QC, SAR analysis, generative chemistry runs, FEP calculation setup and project-update slide generation.